407 related articles for article (PubMed ID: 12509645)
21. Updated neurophysiology of itch.
Ikoma A
Biol Pharm Bull; 2013; 36(8):1235-40. PubMed ID: 23902966
[TBL] [Abstract][Full Text] [Related]
22. Gabapentin for pruritus in palliative care.
Anand S
Am J Hosp Palliat Care; 2013 Mar; 30(2):192-6. PubMed ID: 22556282
[TBL] [Abstract][Full Text] [Related]
23. Chronic Pruritus in the Geriatric Population.
Cao T; Tey HL; Yosipovitch G
Dermatol Clin; 2018 Jul; 36(3):199-211. PubMed ID: 29929593
[TBL] [Abstract][Full Text] [Related]
24. Rifampicin as treatment for pruritus in malignant cholestasis.
Price TJ; Patterson WK; Olver IN
Support Care Cancer; 1998 Nov; 6(6):533-5. PubMed ID: 9833303
[TBL] [Abstract][Full Text] [Related]
25. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
27. Causes, pathophysiology, and treatment of pruritus in the mature patient.
Shevchenko A; Valdes-Rodriguez R; Yosipovitch G
Clin Dermatol; 2018; 36(2):140-151. PubMed ID: 29566918
[TBL] [Abstract][Full Text] [Related]
28. [Clinical effects of olopatadine hydrochloride on pruritus in skin diseases].
Niide M; Okubo Y; Irisawa R; Tsuboi R
Arerugi; 2006 Oct; 55(10):1327-36. PubMed ID: 17072113
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic Itch Management.
Rowe B; Yosipovitch G
Curr Probl Dermatol; 2016; 50():149-54. PubMed ID: 27578084
[TBL] [Abstract][Full Text] [Related]
30. Neuropathic itch.
Oaklander AL
Semin Cutan Med Surg; 2011 Jun; 30(2):87-92. PubMed ID: 21767768
[TBL] [Abstract][Full Text] [Related]
31. Drug-Induced Itch Management.
Ebata T
Curr Probl Dermatol; 2016; 50():155-63. PubMed ID: 27578085
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
33. Itch Management: Physical Approaches (UV Phototherapy, Acupuncture).
Chan IH; Murrell DF
Curr Probl Dermatol; 2016; 50():54-63. PubMed ID: 27578072
[TBL] [Abstract][Full Text] [Related]
34. [Pruritus in liver disease. Pathogenesis and treatment].
Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
[TBL] [Abstract][Full Text] [Related]
35. [Uremic pruritus: an unresolved challenge].
Aucella F; Gesuete A
G Ital Nefrol; 2009; 26(5):585-99. PubMed ID: 19802804
[TBL] [Abstract][Full Text] [Related]
36. [Pruritus associated with cholestasis].
Terán A; Fábrega E; Pons-Romero F
Gastroenterol Hepatol; 2010 Apr; 33(4):313-22. PubMed ID: 19836105
[TBL] [Abstract][Full Text] [Related]
37. The neurology of itch.
Dhand A; Aminoff MJ
Brain; 2014 Feb; 137(Pt 2):313-22. PubMed ID: 23794605
[TBL] [Abstract][Full Text] [Related]
38. Peripheral and central mediators of itch.
Hägermark O
Skin Pharmacol; 1992; 5(1):1-8. PubMed ID: 1575979
[TBL] [Abstract][Full Text] [Related]
39. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.
Schwörer H; Hartmann H; Ramadori G
Pain; 1995 Apr; 61(1):33-37. PubMed ID: 7644246
[TBL] [Abstract][Full Text] [Related]
40. Neurologic Itch Management.
Şavk E
Curr Probl Dermatol; 2016; 50():116-23. PubMed ID: 27578080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
